argenx SE (EBR:ARGX)
479.30
+1.10 (0.23%)
Jun 27, 2025, 5:36 PM CET
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
€1,529,306
Profits / Employee
€615,704
Market Cap
28.87B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UCB SA | 9,378 |
Fagron NV | 3,828 |
Ion Beam Applications | 2,287 |
Nyxoah | 184 |
Onward Medical | 103 |
Hyloris Pharmaceuticals | 49 |
Sequana Medical NV | 48 |
European Medical Solutions | 122 |
argenx SE News
- 7 days ago - argenx gets EU nod for Vyvgart subcutaneous injection - Seeking Alpha
- 7 days ago - argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy - GlobeNewsWire
- 11 days ago - $1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
- 17 days ago - argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease - Benzinga
- 17 days ago - argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease - GlobeNewsWire
- 25 days ago - argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - argenx Announces Results of Annual General Meeting of Shareholders - GlobeNewsWire
- 5 weeks ago - Hot Picks in biotech: argenx, Scholar Rock & Kiniksa - BNN Bloomberg